Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-16

FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

The FDA approved a supplemental application for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) submitted by Eugia US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Piperacillin and tazobactam (Piperacillin and tazobactam)

Snippet

SUPPL AP for PIPERACILLIN AND TAZOBACTAM (PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM)